| Literature DB >> 17452773 |
Josephine C Dorsman1, Marieke Levitus, Davy Rockx, Martin A Rooimans, Anneke B Oostra, Anneke Haitjema, Sietske T Bakker, Jûrgen Steltenpool, Dezsö Schuler, Sheila Mohan, Detlev Schindler, Fré Arwert, Gerard Pals, Christopher G Mathew, Quinten Waisfisz, Johan P de Winter, Hans Joenje.
Abstract
To identify the gene underlying Fanconi anemia (FA) complementation group I we studied informative FA-I families by a genome-wide linkage analysis, which resulted in 4 candidate regions together encompassing 351 genes. Candidates were selected via bioinformatics and data mining on the basis of their resemblance to other FA genes/proteins acting in the FA pathway, such as: degree of evolutionary conservation, presence of nuclear localization signals and pattern of tissue-dependent expression. We found a candidate, KIAA1794 on chromosome 15q25-26, to be mutated in 8 affected individuals previously assigned to complementation group I. Western blots of endogenous FANCI indicated that functionally active KIAA1794 protein is lacking in FA-I individuals. Knock-down of KIAA1794 expression by siRNA in HeLa cells caused excessive chromosomal breakage induced by mitomycin C, a hallmark of FA cells. Furthermore, phenotypic reversion of a patient-derived cell line was associated with a secondary genetic alteration at the KIAA1794 locus. These data add up to two conclusions. First, KIAA1794 is a FA gene. Second, this gene is identical to FANCI, since the patient cell lines found mutated in this study included the reference cell line for group I, EUFA592.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17452773 PMCID: PMC4618213 DOI: 10.1155/2007/151968
Source DB: PubMed Journal: Cell Oncol ISSN: 1570-5870 Impact factor: 6.730